NOTE: It’s easy! Submit your order and Pet’s First Choice will verify your pet’s prescription with your veterinarian. Please allow 24-48 hours for this validation.
With unintended weight loss, you can’t afford to wait
Manage unintended weight loss in cats with Mirataz® (mirtazapine transdermal ointment)
In a clinical study, Mirataz resulted in significant weight gain in cats in as little as 14 days following topical application of 2 mg per day1
Mirataz gives you a practical way to manage your patient’s weight loss without administration of oral medication and does not rely on the cat to eat to be medicated
Mirataz was safe both locally and systemically in a clinical study1
Important Safety Information
Mirataz® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients. Do not use in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves when handling/applying, wash hands after and avoid contact between the treated cat and people or other animals for 2 hours following application. Use with caution in cats with hepatic and kidney disease. Cat’s food intake should be monitored upon discontinuation. Safety has not been evaluated in cats less than 2 kg, less than six months of age or in breeding, pregnant or lactating cats. The most common adverse reactions observed during clinical trials were application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. For product label, including complete safety information, click here.